keyword
MENU ▼
Read by QxMD icon Read
search

Insomnia, medication

keyword
https://www.readbyqxmd.com/read/29223044/association-between-sleep-disorder-and-panic-disorder-in-south-korea-nationwide-nested-case-control-study-of-data-from-2004-to-2013
#1
Han Jin Park, Min Seok Kim, Eun-Cheol Park, Suk-Yong Jang, Woorim Kim, Kyu-Tae Han
After 2010, panic disorders became relatively common in South Korea, with many celebrities confessing to the public that they have panic disorder. The annual number of patients with panic disorder and sleep disorder have been gradually increasing. In light of these increases, we analyzed the relationship between sleep disorder and panic disorder. We used national claim data to design a 1:3 nested case-control study. The study included medical claims filed for 29,312 patients during 2004-2013. We performed conditional logistic regression analysis to investigate the relationship between sleep disorder and panic disorder...
December 5, 2017: Psychiatry Research
https://www.readbyqxmd.com/read/29217495/efficacy-of-violet-oil-a-traditional-iranian-formula-in-patients-with-chronic-insomnia-a-randomized-double-blind-placebo-controlled-study
#2
Zohre Feyzabadi, Fariborz Rezaeitalab, Shapour Badiee, Ali Taghipour, Fatemeh Moharari, Atefeh Soltanifar, Mohammad Reza Ahmadpour
ETHNOPHARMACOLOGICAL RELEVANCE: Violet oil is an ancient herbal drug which has been extensively used to treat insomnia in traditional Iranian Medicine clinics. Violet oil is an almond or sesame oil-based extract of Viola odorata, which is administered as nasal drops. This study aimed to evaluate the efficacy of Violet oil in the treatment of insomnia. METHODS AND MATERIALS: This study was conducted as a 3-arm double-blind randomized trial. A total of 75 patients with chronic insomnia were enrolled and randomly assigned to three groups in Traditional Iranian Medicine Clinic of Mashhad University of Medical Sciences, Mashhad, Iran...
December 4, 2017: Journal of Ethnopharmacology
https://www.readbyqxmd.com/read/29214620/cognitive-behavioral-therapy-for-insomnia-treatment-in-a-military-deployed-operational-setting-utilizing-enlisted-combat-medics-a-quality-and-process-improvement-project
#3
Rohul Amin, Brooke E Wirtz
Insomnia disorder is a prevalent condition especially among the American military, affecting up to 50% of service members. It is shown to affect military performance. Guidelines recommend the use of nonpharmacologic approaches as initial treatment of insomnia. Cognitive behavioral therapy informed insomnia treatment (CBT-I) has the greatest evidence, however it requires specialized training. While deployed in the Middle East in support of US military operations, we faced a resource challenge while caring for service members with insomnia...
October 2017: U.S. Army Medical Department Journal
https://www.readbyqxmd.com/read/29208069/the-delirium-drug-scale-is-associated-to-delirium-incidence-in-the-emergency-department
#4
Patrick Viet-Quoc Nguyen, Lucie Pelletier, Isabelle Payot, Judith Latour
BACKGROUND: The Delirium Drug Scale (DDS) is an evaluation scale developed to assess a patient's drug burden for delirium. The primary goal is to validate the association between the DDS score and the incidence of delirium. METHODS: This study was an observational retrospective cross-sectional chart review study in patients aged 75 years and older. It was carried out in three emergency departments of a tertiary care university health center. Patients were included if a medication list was available...
December 6, 2017: International Psychogeriatrics
https://www.readbyqxmd.com/read/29189334/considerations-in-the-care-of-athletes-with-attention-deficit-hyperactivity-disorder
#5
George G A Pujalte, Jennifer R Maynard, McKennan J Thurston, Walter C Taylor, Mohit Chauhan
OBJECTIVES: Uncover literature pertaining to: (1) attention deficit hyperactivity disorder (ADHD) and how it impacts athletes; (2) ADHD medication effects; (3) regulations regarding ADHD medications; (4) approaches to conditions similar to, and occurring with, ADHD; and (5) use of stimulants. DATA SOURCES: MEDLINE, Embase, PsycINFO, Cochrane Database of Systematic Reviews, Ovid interface. MAIN RESULTS: ADHD can have many effects on athletes and sports participation...
November 20, 2017: Clinical Journal of Sport Medicine: Official Journal of the Canadian Academy of Sport Medicine
https://www.readbyqxmd.com/read/29185897/pharmacological-treatment-of-insomnia-symptoms-in-individuals-with-substance-use-disorders-in-spain-a-quasi-experimental-study
#6
L Grau-López, L Grau-López, C Daigre, R F Palma-Álvarez, L Rodriguez-Cintas, E Ros-Cucurull, C Roncero
INTRODUCTION: Pharmacological treatment of insomnia in patients with addictions has been hardly investigated and there are few researches about it in an inpatient detoxification. The aim of this study was to describe the outcomes of the pharmacological treatment of insomnia in SUD patients admitted to a detoxification unit in Spain, with a focus on the primary substance of abuse and co-occurring mental disorders. METHODS: A quasi-experimental study was conducted in 481 addicted in patients, who were admitted for substances detoxification in Vall d´Hebron University Hospital, Barcelona, Spain, from 2010 to 2015...
November 29, 2017: Substance Use & Misuse
https://www.readbyqxmd.com/read/29183040/oncological-rehabilitation
#7
Oliver Rick, Timm Dauelsberg, Eva-Maria Kalusche-Bontemps
An increasing number of patients are living with or surviving cancer due to improvements in detection and treatment. However, patients who survive cancer may experience functional disabilities that impact on health, quality of life and ability to work. For example, physical disorders may include fatigue, reduced muscle strength, cognitive dysfunction, paresthesia or nutrition problems, while mental symptoms may include anxiety, depression, fear of relapse or insomnia. Multidimensional oncological rehabilitation programs have been developed to address these disabilities and to help cancer patients and long-term survivors to reduce morbidity and to improve quality of life...
2017: Oncology Research and Treatment
https://www.readbyqxmd.com/read/29182724/worsening-anxiety-irritability-insomnia-or-panic-predicts-poorer-antidepressant-treatment-outcomes-clinical-utility-and-validation-of-the-concise-associated-symptom-tracking-cast-scale
#8
Manish K Jha, Abu Minhajuddin, Charles South, A John Rush, Madhukar H Trivedi
Background: We report on the psychometric properties of the 16-item Concise Associated Symptom Tracking Scale (CAST) self-report scale and its clinical utility. Methods: The five-domain (irritability, anxiety, mania, insomnia, and panic) structure of CAST was validated with confirmatory factor analysis (CFA) in Combining Medications to Enhance Depression Outcomes trial participants at baseline (n=664). Correlations with other clinical measures was used for convergent and divergent validity...
November 22, 2017: International Journal of Neuropsychopharmacology
https://www.readbyqxmd.com/read/29170185/dysosmia-and-dysgeusia-associated-with-duloxetine
#9
Katsuyuki Yoshida, Takahiko Fukuchi, Hitoshi Sugawara
Common adverse effects of serotonin-norepinephrine reuptake inhibitors are nausea, dry mouth, dizziness and headache. We describe the case of a patient with dysosmia and subsequent dysgeusia associated with duloxetine. A 68-year-old Japanese woman with a history of type 1 diabetes mellitus, hypertension, insomnia and reflux esophagitis presented to a local hospital with bilateral leg pain; she was treated with duloxetine. However, after 4 weeks, she sensed rotten egg smell, experienced nausea and vomiting and was admitted to our hospital...
November 23, 2017: BMJ Case Reports
https://www.readbyqxmd.com/read/29168225/gaba-modulating-phytomedicines-for-anxiety-a-systematic-review-of-preclinical-and-clinical-evidence
#10
REVIEW
Karen Savage, Joseph Firth, Con Stough, Jerome Sarris
Anxiety disorders are chronic and functionally disabling conditions with high psychological stress, characterised by cognitive symptoms of excessive worry and focus difficulties and physiological symptoms such as muscle tension and insomnia. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter within the central nervous system and is a key target of pharmacotherapies in the treatment of anxiety. Although current pharmaceutical treatments are often efficacious, they may cause undesirable side effects including cognitive decrements and withdrawal symptoms...
November 23, 2017: Phytotherapy Research: PTR
https://www.readbyqxmd.com/read/29147474/new-onset-of-insomnia-in-hospitalized-patients-in-general-medical-wards-incidence-causes-and-resolution-rate
#11
An Ho, Bronson Raja, Richard Waldhorn, Valentina Baez, Idiris Mohammed
Background: Insomnia is common in hospitalized patients. However, no study has examined new onset of insomnia in patients without a prior history of insomnia. Objectives: Incidence of new onset of insomnia in inpatients, associated factors and resolution rate after 2 weeks. Method: This is a prospective observational study conducted at a community hospital. We used the Insomnia Severity Index questionnaire to screen for insomnia in all patients located in the general medical floors from day 3 to day 5 of their hospital stay...
2017: Journal of Community Hospital Internal Medicine Perspectives
https://www.readbyqxmd.com/read/29126458/epidemiology-of-hypertension-in-fulani-indigenous-populations-age-gender-and-drivers
#12
Clement Kufe Nyuyki, George Ngufor, George Mbeh, Jean Claude Mbanya
BACKGROUND: Hypertension is a public health problem and the main contributor to cardiovascular mortality and morbidity. Little is known about hypertension among the minority, diverse and socially disadvantaged 23-24 million Fulani/Peul populations dispersed in West, Central and East Africa, undergoing a transition from traditional to transitional and modern lifestyle. This study describes age and gender variations in blood pressure and drivers of hypertension among rural Fulani population of Cameroon...
November 10, 2017: Journal of Health, Population, and Nutrition
https://www.readbyqxmd.com/read/29120540/-detecting-and-assessing-the-impactof-anticholinergic-medications
#13
Chantal Csajka, Catherine Brémond, Pierre Olivier Lang
Limitation of inappropriate prescribing must be a medical concern in daily practice especially in older patients. In particular, anti-cholinergic drugs (anti-ACh), which are not all explicitly classified as anti-ACh, are commonly prescribed for a wide range of indications (pulmonary obstructive diseases, anxiety, insomnia, urinary incontinence, Parkinson's disease, congestive heart failure). Their prescription is however associated with a reduced quality of life and increased morbidity and mortality. Tools detecting inappropriate prescriptions and clinical scales that quantify the anti-ACh burden contribute, despite some limitations, to secure and optimize these drugs' prescription in this vulnerable population...
November 8, 2017: Revue Médicale Suisse
https://www.readbyqxmd.com/read/29105206/risk-factors-for-psychological-and-psychosomatic-symptoms-among-children-with-malignancies
#14
Kenichi Maeda, Daisuke Hasegawa, Kevin Y Urayama, Shinichi Tsujimoto, Yuriko Azami, Miwa Ozawa, Atsushi Manabe
AIM: With increasing survival rates in paediatric malignancies, the quality-of-life of children during hospitalisation should be given more attention. We aimed to identify factors associated with psychological and psychosomatic symptoms (PPS) that required medication among children hospitalised for treatment of malignancies. METHODS: We retrospectively analysed data of 190 patients aged 2-18 years old. They were diagnosed with malignant diseases and admitted for treatment at St...
November 3, 2017: Journal of Paediatrics and Child Health
https://www.readbyqxmd.com/read/29104908/stress-and-sleep-results-from-the-hispanic-community-health-study-study-of-latinos-sociocultural-ancillary-study
#15
Carmela Alcántara, Sanjay R Patel, Mercedes Carnethon, Sheila Castañeda, Carmen R Isasi, Sonia Davis, Alberto Ramos, Elva Arredondo, Susan Redline, Phyllis C Zee, Linda C Gallo
Hispanics/Latinos face specific sociocultural stressors associated with their marginalized status in the United States. While stress is known to cause poor sleep, the differential effects of the specific stressors faced by Hispanics/Latinos have not been evaluated. Using cross-sectional data from the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study, we conducted weighted generalized linear models to evaluate the associations of acculturation stress, ethnic discrimination, and chronic moderate/severe stress with self-reported sleep outcomes (insomnia symptoms, daytime sleepiness, sleep duration) in individual and aggregate models adjusted for site, socio-demographics, behavioral, and medical conditions...
December 2017: SSM—Population Health
https://www.readbyqxmd.com/read/29096290/insomnia-treatment-in-the-context-of-alcohol-use-disorder-a-systematic-review-and-meta-analysis
#16
REVIEW
Mary Beth Miller, Marissa L Donahue, Kate B Carey, Lori A J Scott-Sheldon
PURPOSE: To determine the efficacy of behavioral and pharmacological interventions for insomnia among individuals with alcohol use disorder (AUD). PROCEDURES: Comprehensive literature searches of psychological, medical, and educational databases were conducted through October 2016. Eligible studies evaluated the efficacy of an insomnia intervention, included a comparison condition, sampled individuals with AUD and either insomnia disorder or complaints of insomnia, assessed sleep-related outcomes, and provided relevant statistics to calculate between-group effect sizes...
December 1, 2017: Drug and Alcohol Dependence
https://www.readbyqxmd.com/read/29083100/mefloquine-for-preventing-malaria-during-travel-to-endemic-areas
#17
REVIEW
Maya Tickell-Painter, Nicola Maayan, Rachel Saunders, Cheryl Pace, David Sinclair
BACKGROUND: Mefloquine is one of four antimalarial agents commonly recommended for preventing malaria in travellers to malaria-endemic areas. Despite its high efficacy, there is controversy about its psychological side effects. OBJECTIVES: To summarize the efficacy and safety of mefloquine used as prophylaxis for malaria in travellers. SEARCH METHODS: We searched the Cochrane Infectious Diseases Group Specialized Register; the Cochrane Central Register of Controlled Trials (CENTRAL), published on the Cochrane Library; MEDLINE; Embase (OVID); TOXLINE (https://toxnet...
October 30, 2017: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/29077902/z-drugs-and-risk-for-falls-and-fractures-in-older-adults-a-systematic-review-and-meta-analysis
#18
Nir Treves, Amichai Perlman, Lital Kolenberg Geron, Angham Asaly, Ilan Matok
Objective: zolpidem, zopiclone, eszopiclone and zaleplon, also known as 'Z-drugs', are commonly used as alternatives to benzodiazepines (BZDs) to treat insomnia. Z-drugs are often perceived as safer than BZDs. We conducted a systematic review and meta-analysis evaluating the association between Z-drugs and fracutres, falls and injuries. Methods: a systematic review was performed using MEDLINE, EMBASE and ClinicalTials.gov. Pooled effect-sizes were calculated comparing Z-drugs users with non-users, using fixed and random-effect models with corresponding 95% confidence of intervals (CI)...
October 25, 2017: Age and Ageing
https://www.readbyqxmd.com/read/29073669/prevalence-of-temporomandibular-disorders-in-rheumatoid-arthritis-and-associated-risk-factors-a-nationwide-study-in-taiwan
#19
Ching-Yueh Lin, Chi-Hsiang Chung, Heng-Yi Chu, Liang-Cheng Chen, Kuo-Hsien Tu, Chang-Huei Tsao, Yung-Tsan Wu, Wu-Chien Chien
AIMS: To investigate the association between temporomandibular disorders (TMD) and rheumatoid arthritis (RA), as well as potential risk factors for TMD and the preventive effect of medications on TMD, by using the Taiwan National Health Insurance Research Database. METHODS: In total, 17,317 patients newly diagnosed with RA and 17,317 matched controls without RA were followed up from 2000 to 2010. Cox regression was used to determine risk factors for developing TMD...
October 2017: Journal of Oral & Facial Pain and Headache
https://www.readbyqxmd.com/read/29066641/adverse-reaction-with-suvorexant-for-insomnia-acute-worsening-of-depression-with-emergence-of-suicidal-thoughts
#20
Jeremy Petrous, Kevin Furmaga
A 59-year-old woman on daily peritoneal dialysis for end-stage renal failure received care at an outpatient psychiatric clinic for her diagnoses that include major depressive disorder, generalised anxiety disorder and insomnia disorder. Although there was partial improvement in the patient's mood and anxiety symptoms with antidepressant treatment, insomnia remained a persistent complaint despite adequate trials of different sleep medications. The novel hypnotic, suvorexant (Belsomra, Merck & Co.) was then initiated at the recommended bedtime dose of 10 mg and was followed by a 15 mg dose the following night...
October 23, 2017: BMJ Case Reports
keyword
keyword
10970
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"